Anesthesia, Cholecystectomy, Laparoscopic, Postoperative Pain
Conditions
Brief summary
Postoperative pain after laparoscopic cholecystectomy can be considerable. Regional techniques such as erector spinae plane (ESP) block or transversus abdominis plane (TAP) block may be suitable for patients at increased risk of postoperative pain. The deep rectus sheath block is a novel block which is a modified version of the conventional rectus sheath block. It was reported in a few case reports that, it may be used for postoperative analgesia in patients undergoing laparoscopic cholecystectomy. The aim of this study is to investigate the postoperative analgesic efficacy of deep rectus sheath block in patients undergoing laparoscopic cholecystectomy.
Detailed description
Patients scheduled for elective laparoscopic gastrectomy will be separated into 2 groups: Control Group and Deep Rectus Sheath Block Group. Patients in Control Group will be received patient controlled analgesia with morphine for postoperative analgesia. Patients in Deep Rectus Sheath Block Group will be performed Deep Rectus Sheath Block at the end of the surgery, along with patient controlled analgesia with morphine for postoperative analgesia. Morphine consumption for first postoperative 24 hours, numerical rating scale scores, amount of rescue analgesic drug, incidence of postoperative nausea and vomiting will be recorded.
Interventions
OTHERIntravenous morphine patient control analgesia
24-hour morphine consumption will be recorded
OTHERIntravenous patient control analgesia
24-hour morphine consumption will be recorded
OTHERDeep rectus sheath block
Deep rectus sheath block will be administered at the end of the surgery.
Sponsors
Istinye University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Age between 18 and 80 years * Patients with American Society of Anesthesiology (ASA) physical status I-II * Patients scheduled for a laparoscopic cholecystectomy
Exclusion criteria
* Allergy to local anesthetics * Coagulopathy * Skin infection at the deep rectus sheath block area * Advanced hepatic or renal failure * Chronic pain syndromes * Alcohol or drug abuse * Severe pulmonary and/or cardiovascular disease * Psychiatric disorders
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Morphine consumption | Postoperative 24 hours | The amount of morphine required by the patient and given by the device will be recorded for the first 24 hours. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative numerical rating scale scores | Postoperative 24 hours | Postoperative pain will be assessed using a numerical rating scale (NRS) (from 0 = no pain to 10 = maximum possible pain) for the first 24 hours. |
| Rescue analgesic drug requirement | Postoperative 24 hours | The amount of rescue analgesic in mg required by the patient will be recorded for the first 24 hours. |
| Incidence of postoperative nausea and vomiting | Postoperative 24 hours | Number of patients developing postoperative nausea and vomiting will be recorded for the first 24 hours |
Countries
Turkey (Türkiye)
Contacts
Primary ContactTaylan Sahin, M.D.
Outcome results
None listed